This NDC is on FDA's drug shortage list (posted Mar 10, 2023)
Product Information
CLONAZEPAM 2 MG TABLET is a generic product labeled by Solco Healthcare US LLC, priced at $0.0398 per EA under NDC 43547040850. Its NADAC has been published 434 times since May 2, 2018.
FDA first approved this application on Jun 28, 2006. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
2 mg/1
Manufacturer
Solco Healthcare US LLCNDC
43547040850
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
CLONAZEPAMApproval Type
Generic (ANDA)
FDA Application
ANDA077856FDA Approved
6/28/2006
TE Code
AB
On Market Since
2/15/2018
Pharmacological Classes
Price Statistics
The NADAC for CLONAZEPAM 2 MG TABLET has been published 434 times since May 2, 2018, and over the history we have for it it has risen 9.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0398 per EA |
|---|---|
| All-time high | $0.0478 (Apr 15, 2020) |
| All-time low | $0.0316 (Nov 20, 2024) |
| 52-week high | $0.0436 |
| 52-week low | $0.0378 |
| Median price | $0.0384 |
| Average price | $0.0391 |
| Largest weekly change | -28.0% (Nov 20, 2024) |
| Weeks tracked | 434 |
| Tracking since | May 2, 2018 |
Generic Alternatives
The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of CLONAZEPAM 2 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for CLONAZEPAM 2 MG TABLET, manufactured by Solco Healthcare US LLC, is $0.0398 per EA (NDC 43547040850), effective Aug 19, 2026.
How has the price of CLONAZEPAM 2 MG TABLET changed over time?
Over the history we have for it, the NADAC for CLONAZEPAM 2 MG TABLET has risen 9.0%. It has been tracked across 434 weekly CMS publications since May 2, 2018.
What are the highest and lowest recorded NADAC prices for CLONAZEPAM 2 MG TABLET?
Since May 2, 2018, the NADAC for CLONAZEPAM 2 MG TABLET has ranged from a low of $0.0316 (Nov 20, 2024) to a high of $0.0478 (Apr 15, 2020), with a median of $0.0384 per EA.
Are there cheaper alternatives to CLONAZEPAM 2 MG TABLET?
4 manufacturers publish a NADAC-priced product with the same active ingredient and strength as CLONAZEPAM 2 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures CLONAZEPAM 2 MG TABLET?
CLONAZEPAM 2 MG TABLET (NDC 43547040850) is labeled by Solco Healthcare US LLC, and CMS classifies it as a generic product.
Is CLONAZEPAM 2 MG TABLET in shortage?
Yes — NDC 43547040850 is currently listed in FDA's drug shortage database (posted Mar 10, 2023).